Förderungen
Alle Förderungen
1,472 Ergebnisse · Seite 29 von 74
- Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)23 Dec 2027noch 445 Tage
- Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)23 Dec 2027noch 445 Tage
- Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)23 Dec 2027noch 445 Tage
- NPS Cooperative Ecosystems Studies Units (CESU) Master Cooperative Agreements31 Dec 2027noch 453 Tage
- DEVCOM ANALYSIS CENTER BROAD AGENCY ANNOUNCEMENT FOR APPLIED RESEARCH04 Jan 2028noch 457 Tage
- Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)06 Jan 2028noch 459 Tage
- NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)06 Jan 2028noch 459 Tage
- Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)06 Jan 2028noch 459 Tage
- NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)06 Jan 2028noch 459 Tage
- Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional)07 Jan 2028noch 460 Tage
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)07 Jan 2028noch 460 Tage
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)07 Jan 2028noch 460 Tage
- Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)07 Jan 2028noch 460 Tage
- Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)07 Jan 2028noch 460 Tage
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)07 Jan 2028noch 460 Tage
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)07 Jan 2028noch 460 Tage
- Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)07 Jan 2028noch 460 Tage
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)07 Jan 2028noch 460 Tage
- Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)07 Jan 2028noch 460 Tage
- Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)07 Jan 2028noch 460 Tage